FEC-95633-78396
3 vaccinations
2 coded responses
11 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 208 / MD
- Registered
- 2022-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-07
Dose 1 — Pfizer-BioNTech
-
2021-04-28
Dose 2 — Pfizer-BioNTech
-
2022-01-05
Dose 3 — Pfizer-BioNTech
-
2022-01-06
Registered in v-safe
-
2022-01-06
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-08
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-01-10
- 2022-01-15
-
2022-01-22
Survey response — day 14, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-01-22
Report sent to call center — day 14, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-25
- 2022-01-26
-
2022-02-02
Survey response — day 28, dose 3MedDRA: Headache, Heart rate increased, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Rapid heart beat and headaches · Healthcare visit (other): Office visit for EKGMedDRA releases: 2024-11 · check-in free text available
-
2022-02-02
Report sent to call center — day 28, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2022-02-04
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-04-06
- 2022-07-06
- 2023-01-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Pfizer-BioNTech | No |
| 2 | 2021-04-28 | Pfizer-BioNTech | No |
| 3 | 2022-01-05 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 11 — day 14, dose 3
Symptoms: COVID
Release 11 — day 28, dose 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release